Pages that link to "Q38318517"
Jump to navigation
Jump to search
The following pages link to Identification of TDRD1 as a direct target gene of ERG in primary prostate cancer (Q38318517):
Displaying 25 items.
- Epigenomic profiling of prostate cancer identifies differentially methylated genes in TMPRSS2:ERG fusion-positive versus fusion-negative tumors (Q27323950) (← links)
- CaV channels and cancer: canonical functions indicate benefits of repurposed drugs as cancer therapeutics (Q28078863) (← links)
- Human phosphodiesterase 4D7 (PDE4D7) expression is increased in TMPRSS2-ERG-positive primary prostate cancer and independently adds to a reduced risk of post-surgical disease progression (Q28269917) (← links)
- Readers of histone methylarginine marks. (Q30359633) (← links)
- Evolving transcriptomic fingerprint based on genome-wide data as prognostic tools in prostate cancer (Q30938412) (← links)
- Validation of Novel Biomarkers for Prostate Cancer Progression by the Combination of Bioinformatics, Clinical and Functional Studies (Q36022437) (← links)
- RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1. (Q36025180) (← links)
- Characterization of 1577 primary prostate cancers reveals novel biological and clinicopathologic insights into molecular subtypes (Q36035812) (← links)
- Novel Gene Expression Signature Predictive of Clinical Recurrence After Radical Prostatectomy in Early Stage Prostate Cancer Patients (Q36043833) (← links)
- Genomic and epigenomic analysis of high-risk prostate cancer reveals changes in hydroxymethylation and TET1. (Q37269294) (← links)
- MNX1 Is Oncogenically Upregulated in African-American Prostate Cancer (Q38734374) (← links)
- The Germ Cell Gene TDRD1 as an ERG Target Gene and a Novel Prostate Cancer Biomarker (Q38766041) (← links)
- Deciphering the function of non-coding RNAs in prostate cancer. (Q38843392) (← links)
- Novel long non-coding RNAs are specific diagnostic and prognostic markers for prostate cancer (Q38909020) (← links)
- Human PDE4D isoform composition is deregulated in primary prostate cancer and indicative for disease progression and development of distant metastases (Q39341456) (← links)
- Characterizing the molecular features of ERG-positive tumors in primary and castration resistant prostate cancer (Q39909790) (← links)
- Androgen receptor profiling predicts prostate cancer outcome (Q40493333) (← links)
- Domain retention in transcription factor fusion genes and its biological and clinical implications: a pan-cancer study (Q47164118) (← links)
- Development and Validation of a 28-gene Hypoxia-related Prognostic Signature for Localized Prostate Cancer. (Q55398136) (← links)
- Stratification of aggressive prostate cancer from indolent disease—Prospective controlled trial utilizing expression of 11 genes in apparently benign tissue (Q57545711) (← links)
- Stromal Gene Expression is Predictive for Metastatic Primary Prostate Cancer (Q58432602) (← links)
- Tissue proteomics outlines AGR2 AND LOX5 as markers for biochemical recurrence of prostate cancer (Q60051002) (← links)
- The Chinese Medicinal Formulation Guzhi Zengsheng Zhitongwan Modulates Chondrocyte Structure, Dynamics, and Metabolism by Controlling Multiple Functional Proteins (Q60313272) (← links)
- FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes (Q93053616) (← links)
- The DNA methylation landscape of advanced prostate cancer (Q97531381) (← links)